PACTR202003823226570
Not yet recruiting
未知
Pragmatic Trial for HIV Pre-Exposure Prophylaxis Roll-Out in Tanzania
niversity of Oslo0 sites2,500 target enrollmentFebruary 25, 2020
ConditionsHIV/AIDS
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- HIV/AIDS
- Sponsor
- niversity of Oslo
- Enrollment
- 2500
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. men who have sex with men
- •2\. female sex workers
- •3\. age 18 years and above
- •4\. resident of the participating region
- •5\. HIV negative
- •6\. Able to offer informed consent
- •7\. having an internet enabled mobile phone
Exclusion Criteria
- •1\. pregnant women
- •2\. participants with serum Creatinine clearance \< 60 ml/min
- •3\. Not willing to take daily medication
- •4\. Allergy or contraindications to any medication within the PrEP regime
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 4
The PrEDIRA StudyPACTR202109545700165Childrens Investment Fund Foundation400
Terminated
Phase 4
Implementation of Human Immunodeficiency Virus (HIV) pre-exposure prophylaxis with antiretroviral medications amongst men at high risk for HIV infection; a demonstration projectHIV preventionInfection - Acquired immune deficiency syndrome (AIDS / HIV)Public Health - Other public healthACTRN12615000032550Cairns and Hinterland Hospital and Health Service3,000
Completed
Phase 4
The Victorian Pre-Exposure Prophylaxis Demonstration Project- VicPrEPHIV prevention trial for people at risk of HIVACTRN12617000196347Alfred Health100
Active, not recruiting
Phase 1
HIV prevention study with HIV-medicine in gay man in Belgium at high risk for acquiring HIV.HIV preventionTherapeutic area: Health Care [N] - Environment and Public Health [N06]EUCTR2015-000054-37-BEInstitute of Tropical Medicine200
Completed
Not Applicable
Assessment of Pre-Exposure Prophylaxis (PrEP) Administered at Sexually Transmitted Disease (STD) ClinicsHIV InfectionsNCT01632995National Institute of Allergy and Infectious Diseases (NIAID)557